Antimicrobial activity and cytotoxic and epigenetic effects of tannic acid-loaded chitosan nanoparticles Authors: Marzieh Rashidipour, Saber Abbaszadeh, Mehdi Birjandi, Naser Pajouhi, Shahram Ahmadi Somaghian, Gholamreza Goudarzi, Soroosh Shahryarhesami, Mostafa Moradi Sarabi, Esmaeel Babaeenezhad Published: 2024 ABSTRACT Tannic acid (TA) is a potent antitumor agent, but its low bioavailability and absorption limit its use. In this study, it was loaded into chitosan-based nanoparticles (Chi-NPs) to overcome these limitations and to improve its antimicrobial and anticancer activities. TA-loaded Chi-NPs (Chi-TA-NPs) were synthesized using the ionic gelation method and physicochemically characterized by FE-SEM, FTIR, XRD, PDI, DLS, and zeta potential analysis. Additionally, the antimicrobial activity of Chi-TA-NPs against two G+ bacterial strains, two G− bacterial strains, and a fungal strain (Candida albicans) was investigated using the microbroth dilution method. MTT assay was used to examine the cytotoxic effects of Chi-TA-NPs on HepG2 cells. The expression of DNA methyltransferase 1 (DNMT1), DNMT3A, and DNMT3B was examined in HepG2 cells using RT-qPCR. The amount of 5-methylcytosine in the HepG2 cell-derived genomic DNA was measured using ELISA. FE-SEM micrographs showed the loading of TA into the chitosan-based formulation. The peaks detected in the XRD and FTIR analyses confirmed the formation of the Chi-TA-NPs. The PDI value (0.247 ± 0.03), size (567.0 ± 25.84 nm), and zeta potential (17.0 ± 5.86 mV) confirmed the relative stability of Chi-TA-NPs. A constant release profile in line with the Korsmeyer-Peppas model was detected for Chi-TA-NPs, such that approximately 44% of TA was released after 300 min. In addition, Chi-TA-NPs exhibited effective antimicrobial activity against the studied microbial strains, as manifested by MIC values ranging from 250 to 1000 µg/mL. Chi-TA-NPs induced cytotoxicity in liver tumor cell line, with an IC50 value of 500 µg/mL. Furthermore, Chi-TA-NPs considerably decreased the expression of DNMT1 (2.52-fold; p = 0.01), DNMT3A (2.96-fold; p = 0.004), and DNMT3B (2.94-fold; p < 0.0001). However, 5-methylcytosine levels in HepG2 cells were unaffected by Chi-TA-NPs treatment (p = 0.62). Finally, the antimicrobial, cytotoxic, and epigenetic effects of Chi-TA-NPs were more pronounced than those of free TA and the unloaded Chi-NPs. In conclusion, Chi-TA-NPs exhibit promising potential for reducing microbial growth and promoting cytotoxicity in liver cancer cells. Introduction Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, with approximately 700,000 deaths annually1. HCC has been shown to be related to genetic and environmental epigenetic factors including family history, alcohol consumption, hepatitis virus infection, and aflatoxin exposure2. Epigenetic modifications play a crucial role in HCC pathogenesis3. These inherited changes affect gene expression patterns without altering DNA sequence4,5. DNA methylation is an important epigenetic modification that occurs at the promoter CpG islands of tumor suppressor genes and is associated with gene silencing and cancer development6,7. DNA is methylated by three active DNA methyltransferases (DNMTs), DNMT3A, DNMT3B, and DNMT18,9. Several studies have demonstrated an association between HCC pathogenesis and alterations in DNA methylation patterns resulting from DNMTs upregulation10,11. The use of bioactive compounds is an effective approach suggested by researchers to normalize methylation status in a wide range of cancers, including HCC12. Most commercially available anticancer drugs have side effects in patients, and chemoresistance develops after some while13. Tannic acid (TA) is a well-known tannin that consists of gallic acid molecules esterified to hydroxyl groups14–16. It is abundant in plants including grains, nuts, fruits, tea, and oaks17,18. Numerous studies have validated TA as a compound with antioxidant19, anti-inflammatory20, antimicrobial21, antifungal22, antiviral23, and anticancer properties24,25. However, TA administration has limitations in biological systems, such as its poor bioavailability26. Some researchers have determined that TA has a 50% uptake in the rat small intestine and that it does not entirely pass through the intestinal wall26. Nanoparticles (NPs) are often recommended for enhancing the bioavailability of drugs and phytochemicals27. Targeted drug delivery via nanoparticle application is one way to increase the shelf life, effectiveness, stability, and absorption of drugs and bioactive compounds28. Chitosan (Chi) based-nanoparticles (Chi-NPs) have been widely used for drug delivery by encapsulating active ingredients or drugs and providing controlled release29–31. Chi, a biological polymer derived from chitin deacetylation, is composed of D-glucosamine and N-acetyl-D-glucosamine units32. Among the biological properties of Chi, it has high biocompatibility, biodegradability, nontoxicity, and low immunogenicity30. The main objective of this study was to formulate TA-loaded Chi-NPs (Chi-TA-NPs) and evaluate their potential antimicrobial, cytotoxic, and epigenetic effects on HepG2 human HCC cells and microbial pathogens. To the best of our knowledge, this is the first study to determine the cytotoxic and epigenetic effects of Chi-TA-NPs on HCC by evaluating global DNA methylation and DNMTs expression. Materials and methods The chemicals used in this study were acquired from Gibco Invitrogen (UK), Sigma-Aldrich (UK), and Merck (Darmstadt, Germany). Sodium tripolyphosphate (Sodium TPP; cat. no. 238503), Chi with a 75–85% deacetylation degree (molecular weight = 27 kDa; cat. no. 448869), acetic acid (cat. no. A6283), and TA (cat. no. 403040) were obtained from Sigma-Aldrich (UK). Formulation of Chitosan-based nanoparticles (Chi-NPs) and tannic acid-loaded Chi-NPs (Chi-TA-NPs) Chitosan-based nanoparticles (Chi-NPs) were formulated using the ionic gelation method28,31. First, 0.2% (v/v) acetic acid was used to prepare the Chi solutions (0.125, 0.25, 0.5, and 1%). The solutions were vigorously stirred using a magnetic stirrer (HMS8805, Germany) for 12 h at pH 4.7. Next, TPP solutions (0.125, 0.25, 0.5, and 1%) were prepared as the aqueous solutions. After preparing the solutions, a filter paper (0.45 µ pore size) was used to eliminate unsolvable particles. Subsequently, TPP solution (5 mL) was mixed dropwise with Chi solution (20 mL), and the mixture was agitated for 10 min. To prepare the Chi-TA-NPs, 5 mg of TA (0.625, 1.25, 2.5, and 5 mg) was poured into the Chi solution before adding the TPP solution. Subsequently, uninterrupted stirring was applied for 12 h. The produced NPs were freeze-dried using a freeze-drying instrument (Alpha1-2 LD plus, Germany) and maintained at 4 °C for future analysis. Optimized levels of the constituents (1% Chi, 0.5% TPP, and 5 mg TA) were used to prepare NPs28. Encapsulation efficiency The encapsulation efficiency was evaluated by pouring 2 M hydrochloric acid (4 mL) into a test tube containing lyophilized hydrogel (0.02 g). The obtained solution was ultrasonicated (UP200H, Germany) for 30 min. Subsequently, the solution was filtered using filter paper, and the total volume was increased to 10 mL using ddH2O. The amount of TA incorporated into the formulation was determined by monitoring the absorbance of the sample at 254 nm (Shimadzu UV-1900i, Japan)31,33. The following equation was used to calculate the encapsulation efficiency31: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\text{Encapsulation Efficiency}}\left( \% \right) = 100 \times \left( {\frac{{{\text{Mass}}\,{\text{of}}\,{\text{loaded}}\,{\text{TA}}}}{{{\text{Mass}}\,{\text{of}}\,{\text{initial}}\,{\text{TA}}}}} \right).$$\end{document} Physicochemical evaluation of the NPs Size, polydispersity index (PDI), and zeta potential The size distribution and zeta potential of Chi-NPs and Chi-TA-NPs were evaluated using dynamic light scattering (Malvern Instruments Ltd., Malvern, UK). Colloidal samples were dispersed in ddH2O at a ratio of 1:1000 (v/v) to prepare the samples. The samples were evaluated in triplicate (at 25 °C) at the same angle using this apparatus33. Field emission scanning electron microscopy (FE-SEM) Briefly, freeze-dried chitosan-based tannic acid formulation and chitosan-based formulation (stored at − 50 °C for 24 h) were placed on a stub, sputter-coated with gold, and analyzed at 15 kV using a TESCAN MIRA3 field-emission scanning electron microscope (TESCAN, Czech Republic)34. Fourier-transform infrared (FTIR) spectroscopy FTIR spectroscopy was used to characterize the chemical groups and bonds in Chi-TA-NPs. FTIR spectroscopy was conducted to measure the infrared absorbance spectra of different compounds, such as Chi, TPP, Chi-NPs, and Chi-TA-NPs (BRUKER, TENSOR 27. Germany)34. X-ray diffraction (XRD) analysis The XRD profiles of the formulations were determined using a diffractometer (Dmax 2100; USA). UV-filtered with a current of 20 mA and potential of 40 kV was used. The scan rate was 4°/min over a range of 0º-90º of diffraction angle (2θ)35. Release kinetics test A dialysis bag was used to determine the amount of TA that was released. First, it was kept in ddH2O at 25 °C for 24 h. Then, the Chi-TA-NPs solution (5 mL) containing 1.5 mg of TA as the donor was placed in a dialysis bag (molecular weight cut-off = 12000 Da). The filled bag was then immersed in a solution including PBS (60 mL) and ethanol (30 mL), as recipients of TA (pH = 7.4). The recipient solution was then stirred at 600 rpm. The release kinetics of TA was analyzed by examining the recipient solution (1 mL) after 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, and 300 min and by replacing it with a fresh solution (1 mL; pH = 7.4). TA concentrations were quantified spectrophotometrically at 254 nm (Shimadzu UV-1900i, Japan)36. The cumulative release of TA from the prepared NPs was determined using the following equation:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\text{Cumulative}}\:{\text{release}}\:\left( \% \right) = \sum\limits_{{t = 0}}^{t} {\frac{{{\text{Mt}}}}{{{\text{M0}}}} \times \:100} .$$\end{document} After determining the cumulative release, a graph representing released TA against time was plotted. The mechanism of TA release from the NPs was assessed using the Korsmeyer-Peppas equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{{\text{Mt}}}}{{{\text{M}}\infty }} = {\text{Kt}}^{n} .$$\end{document} Mt is the level of released TA at each time, M∞ is the level of TA at the start of the experiment, t shows the release time, K indicates the release kinetic constant, and n represents the characteristic power required for release. The mechanism of release is explained according to the n value and mimics the Fickian and non-Fickian patterns. n ≤ 0.43 shows case I transport (Fickian release); however, n = 0.85 exhibits case II transport (non-Fickian release). 0.43 < n < 0.85 represents a non-Fickian pattern, and the release mechanism includes diffusion and inflation33. A graph was drawn in a linear form using Ln Mt/M ∞ against Ln (t) to calculate the K and n values. pH test To assess pH changes, unloaded and TA-loaded NPs (0.5 g) were dispersed in 10 mL ddH2O with stirring and sonication. Then, pH was measured for 90 days (0, 1, 2, 7, 14, 30, 45, 60, and 90 days). Evaluation of antimicrobial activity The antimicrobial effects of Chi-TA-NPs were examined using several strains of pathogens, such as Staphylococcus aureus (S. aureus) (ATCC 12600), Listeria monocytogenes (L. monocytogenes) (PTCC 1297), Escherichia coli (E. coli) (PTCC 1395), Klebsiella pneumoniae (K. pneumoniae) (PTCC 1290), and Candida albicans (C. albicans) (PTCC 5072), which were purchased from the National Cell Bank of Iran (Pasteur Institute, Tehran, Iran). Antimicrobial properties were assessed by identifying the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC) using the microdilution method in line with the CLSI standard method37. Briefly, stock solutions of Chi-NPs, Chi-TA-NPs, TA, ceftriaxone, and fluconazole were prepared using Mueller-Hinton Broth medium (MHB, Merck, Germany) containing 10% dimethyl sulfoxide (DMSO) for bacterial pathogens and Sabouraud Dextrose Broth (SDB, Merck, Germany) containing 10% DMSO for fungal pathogens. Chi-NPs and Chi-TA-NPs were completely dispersed by sonication for 15–20 min at room temperature. Serial dilutions were performed to obtain a concentration range of 5000 –3.125 µg/mL. Each subsequent well contained half the concentration in the previous well. The prepared concentrations were loaded into a microplate (96-well), and a suspension comprising microbial strain (1.5 × 108 CFU/mL) was immediately added. The plates were then incubated at 37 °C for 24 h. After incubation, the microbial viability was examined using 2,3,5-Triphenyltetrazolium chloride. The results were obtained by observing the color of the wells as follows: pink wells exhibited live microbes, and non-colored wells showed microbial inhibition. To determine MBC and MFC, wells with no color formation were seeded (5 µL) onto Muller-Hinton Agar and Sabouraud Dextrose Agar plates for bacterial and fungal pathogens, respectively. The cultured plates were maintained at 37 °C for 24 h, and the plates with the minimum concentrations of Chi-NPs, Chi-TA-NPs, TA, ceftriaxone, and fluconazole that exhibited no colony growth were reported as MBC or MFC37. In this study, DMSO (10%) was considered as negative control. HepG2 cell culture Human hepatocellular HepG2 cancer cells were obtained from the National Cell Bank of Iran (Pasteur Institute, Tehran, Iran). HepG2 cells were grown in a prepared culture medium (RPMI 1640) containing 10% FBS, 2 mM glutamine, penicillin (100 U/mL), and streptomycin (100 µg/mL) under suitable conditions in an incubator with CO2 (5%) at 37 °C38. MTT assay To evaluate the cell toxicity of Chi-NPs, TA, and Chi-TA-NPs, cells at a density of 3 × 104 were cultured in six-well plates after the addition of the desired amount of complete culture medium and allowed to attach for 48 h to prepare for treatment with Chi-NPs, TA, and Chi-TA-NPs. Cell viability was assessed using the MTT assay38. Briefly, cells were exposed to five different concentrations (10, 50, 100, 500, and 1000 µg/mL) of each compound for 48 h, as described in our recent study28. After treatment, the cells were incubated with MTT solution (0.5 mg/mL), followed by exposure to 100 µL of DMSO. Finally, absorbance was measured at 570 nm using an ELISA reader (Stat Fax 4700, USA). Each experiment was conducted three times. The Ethics Committee of the Lorestan University of Medical Sciences reviewed and accepted the methodology of this study (IR.LUMS.REC.1397.085). RNA isolation and reverse transcription-quantitative real-time PCR (RT-qPCR) Total RNA was isolated from the cells using an RNA Isolation Reagent (Roche Applied Science, Germany) according to the manufacturer’s protocol. Electrophoresis on a 2% formaldehyde containing 1.5% agarose gel was used to evaluate the integrity of the separated RNA. The extracted RNA was stored at − 80 °C until further analysis. Complementary DNA (cDNA) synthesis was performed with isolated RNA (2.0 µg) and oligo dT primers using an M-MuLV RT kit (MBI Fermentas, Lithuania). DNase I (Yekta Tajhiz Azma, Iran) was used to extract DNA from the RNA samples prior to cDNA synthesis. Gene expression levels of DNMT1, DNMT3A, DNMT3B, and GAPDH were analyzed in triplicate using the Corrbet sequence detection system (Rotor Gene 6000). Primer sequences used for RT-qPCR are available in Table 1. Relative expression was determined using the 2–ΔΔCt standard method39,40.Table 1Primers selected for RT-qPCR.GenePrimer positionPrimer (5′ → 3′)Product length (bp)GAPDHForwardReverseGGTCGGAGTCAACGGATTTGGTGATGACAAGCTTCCCGTTCT194DNMT1ForwardReverseTACCTGGACGACCCTGACCTCGTTGGCATCAAAGATGGACA103DNMT3AForwardReverseGGGTGTTCCAGGGTAACATTGAGTATTGATGAGCGCACAAGAGAGC111DNMT3BForwardReverseGGCAAGTTCTCCGAGGTCTCTGTGGTACATGGCTTTTCGATAGGA113 Table 1Primers selected for RT-qPCR.GenePrimer positionPrimer (5′ → 3′)Product length (bp)GAPDHForwardReverseGGTCGGAGTCAACGGATTTGGTGATGACAAGCTTCCCGTTCT194DNMT1ForwardReverseTACCTGGACGACCCTGACCTCGTTGGCATCAAAGATGGACA103DNMT3AForwardReverseGGGTGTTCCAGGGTAACATTGAGTATTGATGAGCGCACAAGAGAGC111DNMT3BForwardReverseGGCAAGTTCTCCGAGGTCTCTGTGGTACATGGCTTTTCGATAGGA113 Primers selected for RT-qPCR. Forward Reverse GGTCGGAGTCAACGGATTTGG TGATGACAAGCTTCCCGTTCT Forward Reverse TACCTGGACGACCCTGACCT CGTTGGCATCAAAGATGGACA Forward Reverse GGGTGTTCCAGGGTAACATTGAG TATTGATGAGCGCACAAGAGAGC Forward Reverse GGCAAGTTCTCCGAGGTCTCTG TGGTACATGGCTTTTCGATAGGA Genomic DNA extraction and global DNA methylation analysis Global DNA methylation was analyzed in DNA extracted from the cells using an ELISA kit (Zymo Research, Germany) following the manufacturer’s protocol, as previously explained41. Briefly, 100 ng of isolated genomic DNA was denatured (98 °C for 5 min) and coated onto the wells of the plate by incubation with 5-mC coating buffer (37 °C for 1 h). After incubation, the wells were washed three times with 200 µL of 5-mC ELISA buffer, and then 100 µL of an antibody mix comprising anti-5-methylcytosine and secondary antibody conjugated with horseradish peroxidase (HRP) was added to each well. The plate was covered with foil and incubated at 37 °C for 1 h. Next, the antibody mix was removed from the wells using 5-mC ELISA buffer, and HRP developer (100 µL) was added to each well and incubated at room temperature for 1 h. Finally, optical density (OD) was measured at 450 nm using an ELISA plate reader (Stat Fax 4700, USA). Statistical analysis Statistical analysis was conducted using the SPSS 26 software (SPSS, Inc., Chicago, IL, USA) and GraphPad Prism (Version 9.01). Results were expressed as mean ± standard deviation (SD). Data were compared between groups using one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. Statistical differences among the groups were reported to be significant at p ≤ 0.05. Results and discussion Physicochemical analysis of Chi-TA-NPs Previous studies have emphasized the diverse biological activities of TA, including antimicrobial and anticancer properties21,24. Despite its useful properties, the low bioavailability and absorption of TA limits its broad application17,26. Several studies have suggested the use of a wide range of NPs to increase the solubility and bioavailability of phytochemicals42,43. Chi is a promising carrier due to its solubility in aqueous acidic media, provided by the -NH2 groups of D-glucosamine, efficient bio-adhesiveness, high loading efficiency, and good permeabilization44. In current study, FE-SEM analysis of the prepared formulations showed that Chi-TA-NPs with a polymeric nature were successfully synthesized from Chi. As shown in Fig. 1A, FE-SEM images revealed that chitosan-based formulation had a porous matrix, whereas chitosan-based tannic acid formulation had a compact and dense matrix (Fig. 1B). The electrostatic bonds between the TPP functional groups and Chi amino (-NH2) groups likely form a porous matrix in Chi-TA-NPs45. This porous structure was transformed into a dense matrix after interaction with TA (Fig. 1B). In addition, our results indicated that the encapsulation efficiency was 44.41 ± 3.97% (Fig. 2A). The comparatively high encapsulation efficiency achieved in this study may have resulted from the optimum stirring conditions used during the nanoparticle synthesis35.Fig. 1Physicochemical and pH analyses of chitosan-based tannic acid nanoparticles (Chi-TA-NPs). (A and B) FE-SEM images of chitosan-based formulation (Chi formulation) (A) and chitosan-based tannic acid formulation (Chi-TA formulation) (B). (C) FTIR analysis of chitosan nanoparticles (Chi-NPs) (a), Chi-TA-NPs (b), TPP (c), and chitosan (d). (D and E) XRD profiles of Chi-TA-NPs (D) and Chi-NPs (E). (F) pH of NP and Chi-TA-NPs for 90 days.Fig. 2Physicochemical properties (A), particle size distribution (B and C), and zeta potential (D and E) of chitosan nanoparticles (Chi-NPs) and tannic acid-loaded chitosan nanoparticles (Chi-TA-NPs). Physicochemical and pH analyses of chitosan-based tannic acid nanoparticles (Chi-TA-NPs). (A and B) FE-SEM images of chitosan-based formulation (Chi formulation) (A) and chitosan-based tannic acid formulation (Chi-TA formulation) (B). (C) FTIR analysis of chitosan nanoparticles (Chi-NPs) (a), Chi-TA-NPs (b), TPP (c), and chitosan (d). (D and E) XRD profiles of Chi-TA-NPs (D) and Chi-NPs (E). (F) pH of NP and Chi-TA-NPs for 90 days. Physicochemical properties (A), particle size distribution (B and C), and zeta potential (D and E) of chitosan nanoparticles (Chi-NPs) and tannic acid-loaded chitosan nanoparticles (Chi-TA-NPs). The physicochemical properties of the formulations, including size, zeta potential, and PDI, were also evaluated (Fig. 2A, D, and E). The physical characteristics of NPs are among the most important parameters, because smaller particles can provide a larger surface area for absorption46,47. Our findings showed that the diameter of Chi-TA-NPs was 567.0 ± 25.84 nm and that of Chi-NPs was 988.7 ± 31.00 nm. Previous studies have reported a similar range of particle sizes using the ionic gelation method33,39. Depending on the synthesis method, the Chi particle size varied between 50 and 600 nm35,48,49. Interestingly, loading TA into Chi-NPs affected nanoparticle size by decreasing the size from 988.7 ± 31.00 nm for Chi-NPs to 567.0 ± 25.84 nm for Chi-TA-NPs (Fig. 2A, B, and C). The smaller size of Chi-TA-NPs can be explained by the presence of crosslinking between three functional groups, including the phosphate group of TPP, the -NH2 groups of Chi, and the abundant TA hydroxyl groups. PDI values for Chi-TA-NPs and Chi-NPs were 0.247 ± 0.03 and 0.528 ± 0.02, respectively (Fig. 2A). The PDI reflects the homogeneity of the size distribution on a scale of 0 to 1. PDI values greater than 0.7 denote a broad particle size distribution50. Our findings indicated that Chi-TA-NPs with a PDI of 0.247 ± 0.03 may exhibit a homogeneous particle size28,46. In this study, prepared Chi-TA-NPs and Chi-NPs showed a positive surface charge, as manifested by zeta potential values of + 17.0 ± 5.86 mV and + 3.93 ± 0.61 mV, respectively (Fig. 2A, B and C). These results were supported by previous studies reporting similar values for Chi-NPs51,52. The positive charge detected was probably due to the presence of the cationic Chi polymer in the prepared formulation28,51 and may provide relative stability to the prepared Chi-TA-NPs. FTIR spectroscopy analysis demonstrated that the absorbance peaks for Chi-NPs at 3600 –3200 cm[-1 were highly flattened, which was related to the hydrogen bonds of the OH and NH groups (Fig. 1C; arrow). Intriguingly, these absorbance peaks relatively disappeared in Chi-TA-NPs (stars), which may be due to the incorporation of TA into the cavities of the formulation. In addition, Chi-NPs exhibited absorption peaks at 1163 cm[-1 and 1216 cm[-1(arrowheads), highlighting the PO3 and P = O groups of sodium TPP, respectively, and the cross-linking formed by sodium TPP53. Similar results were reported in previous studies that determined the FTIR spectra of Chi and TPP53–55. For Chi-TA-NPs, specific absorption peaks were detected at 2932.60 (O–H stretching), 656.97 (C = C stretching), and 3367.47 cm[-1 (C–H stretching), which were associated with TA. The absorption peaks at 1153, 1638, 1561.29, and 3600 –3200 cm[-1 in the FTIR spectra of Chi-TA-NPs indicated Chi-related C-O, amide II, NH2 (N-H bonding), C = O, and OH groups, respectively (Fig. 1C). Furthermore, wide and weak absorption peaks at 1153 cm[-1 and 1156.07 cm[-1 were associated with Chi-TA-NPs, indicating the P = O groups of sodium TPP. This peak in the relevant spectrum indicates the cross-connections formed by sodium TPP. An absorption peak was observed at 2937 cm[-1 for Chi-TA-NPs, showing alkane medium stretching of TA. Moreover, there were strong absorbance peaks at 1191 cm[-1 and 3600 –3200 cm[-1 corresponding to the stretching of CO and tensile vibrations of OH and NH2 groups related to TA, respectively56. The structures of Chi-NPs and Chi-TA-NPs were investigated in terms of crystallinity using XRD analysis. Detection of two typical peaks at 2θ = 12° and 2θ = 20° in the XRD profile of Chi confirms its crystallinity35,57. However, the XRD patterns of Chi-NPs and Chi-TA-NPs revealed no specific peaks (Fig. 1D and E), indicating the disintegration of the natural chitosan structure. Our findings are consistent with those of earlier studies that demonstrated the absence of these peaks following the formation of Chi-NPs using TPP or the encapsulation of phytochemicals49. Interestingly, the peak intensities decreased when TA was encapsulated in Chi-NPs, suggesting structural changes58. These results support the hypothesis that TA is incorporated or distributed within the polymers of Chi-sodium TPP, and that an unstructured complex is developed via intermolecular interactions. Release of TA from Chi-TA-NPs Cumulative TA release was measured in vitro to investigate the trend of TA release from the Chi-TA-NPs. As shown in Fig. 3A, approximately 44% of the initial TA was released after 300 min (6.84 µg/mL). This finding is consistent with those of previous studies that reported a continuous release pattern of polyphenols from Chi-NPs28,34. The sustainable and controllable release of TA is beneficial for developing effective cancer therapies39,59. The mechanism of TA release from Chi-TA-NPs was estimated using the Korsmeyer-Peppas model. The n, R2, and K values were 0.82, 0.98, and 0.004, respectively (Fig. 3B). The calculated n value indicated that a mechanism involving diffusion and matrix relaxation was responsible for the release of TA from Chi-TA-NPs33. The release pattern of an active ingredient from polymeric NPs depends on several factors, including nanoparticle shape and size, polymer molecular mass, reactant characteristics, and interaction modes60.Fig. 3Tannic acid (TA) release pattern in PBS (pH 7.4) from chitosan-based tannic acid nanoparticles (Chi-TA-NPs). (A) Cumulative release of TA from Chi-TA-NPs for 300 min. (B) The Korsmeyer-Peppas method was applied to determine n. Tannic acid (TA) release pattern in PBS (pH 7.4) from chitosan-based tannic acid nanoparticles (Chi-TA-NPs). (A) Cumulative release of TA from Chi-TA-NPs for 300 min. (B) The Korsmeyer-Peppas method was applied to determine n. Evaluation of Chi-TA-NPs pH during 90 days The pH test is an important stability test of NPs. We found that the concentration of H+ increased ~ 1.4 folds after 90 days in the formulation, which may be explained by the hydrolysis of Chi and liberation of glucosamine and oligosaccharides (Fig. 1F)31,61. The near-neutralizing pH of Chi-TA-NPs over time may be beneficial, because the acidic pH of the cancer cell microenvironment considerably enhances proliferation and aggressiveness62. Antimicrobial effects of Chi-TA-NPs In this study, the antimicrobial properties of free TA and Chi-TA-NPs against bacterial and fungal pathogens were investigated using the broth microdilution method. As indicated in Table 2, the gram-positive bacterial strain L. monocytogenes and fungal strain C. albicans exhibited greater sensitivity to Chi-TA-NPs than to free TA. Chi-TA-NPs effectively inhibited the growth of L. monocytogenes and C. albicans at concentrations of 250 and 1000 µg/mL, respectively, whereas free TA suppressed the growth of these pathogens at concentrations of 1250 and 2500 µg/mL, respectively. In addition, Chi-TA-NPs showed a lower MIC against gram-negative bacterial strains, such as E. coli and K. pneumoniae (1000 and 250 µg/mL, respectively), than free TA (5000 and 625 µg/mL, respectively). The greater antimicrobial activity of Chi-TA-NPs may be explained by the sustained release of TA from the NPs during the experiment, resulting in superior inhibitory effects63. In addition, the increased antibacterial activity of Chi-TA-NPs can be attributed to their positive surface charge (zeta potential = + 17.0 ± 5.86 mV). A positive charge on the surface of the particles facilitates better interactions with the negatively charged bacterial cells, allowing the drug to pass through the bacterial cell wall49. Furthermore, particles carrying a positive charge can impair the electron transport chain within the bacterial membrane64. Interestingly, the gram-positive bacterial strain S. aureus was completely resistant to free TA and Chi-TA-NPs, as reflected by MIC values greater than 5000 and 1000 µg/mL, respectively. This may be due to the thickening of the peptidoglycan layer in the cell wall structure, leading to increased resistance to nanoparticle penetration65–67. However, NPs penetrate the cell walls of gram-negative bacteria more easily because of the lower thickness of the peptidoglycan layer65–67. Interestingly, the MIC of ceftriaxone and fluconazole as positive controls against the studied microbial strains were closer to those of Chi-TA-NPs than to those of free TA. These results are in accordance with those of previous studies, which showed that encapsulating phenolic compounds in polymeric NPs promotes antimicrobial activity68. In summary, our findings demonstrated that loading TA into Chi-NPs promoted their antimicrobial effects, indicating the promising potential of Chi-TA-NPs in controlling microbial diseases.Table 2Antimicrobial effects of chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and Chitosan-based tannic acid nanoparticles (Chi-TA-NPs). The results were reported in µg/mL.MicroorganismsK. pneumoniaPTCC 1290E. coliPTCC 1395S. aureusATCC 12,600L. monocytogenesPTCC 1297C. albicansPTCC 5072MIC MBCMICMBCMICMBCMICMBCMICMBCChi-NPs> 1000> 10001000> 1000> 1000> 1000250500> 10001000TA62512505000 > 5000> 5000 > 50001250500025005000Chi-TA-NPs25010001000 > 1000 > 1000 > 100025010001000> 1000Ceftriaxone/fluconazole1.561.563.126.2412.55012.550100200PTCC Persian Type Culture Collection, ATCC American Type Culture Collection, MIC minimum inhibitory concentration, MBC minimum bactericidal concentration, MFC minimum fungicidal concentration. Table 2Antimicrobial effects of chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and Chitosan-based tannic acid nanoparticles (Chi-TA-NPs). The results were reported in µg/mL.MicroorganismsK. pneumoniaPTCC 1290E. coliPTCC 1395S. aureusATCC 12,600L. monocytogenesPTCC 1297C. albicansPTCC 5072MIC MBCMICMBCMICMBCMICMBCMICMBCChi-NPs> 1000> 10001000> 1000> 1000> 1000250500> 10001000TA62512505000 > 5000> 5000 > 50001250500025005000Chi-TA-NPs25010001000 > 1000 > 1000 > 100025010001000> 1000Ceftriaxone/fluconazole1.561.563.126.2412.55012.550100200PTCC Persian Type Culture Collection, ATCC American Type Culture Collection, MIC minimum inhibitory concentration, MBC minimum bactericidal concentration, MFC minimum fungicidal concentration. Antimicrobial effects of chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and Chitosan-based tannic acid nanoparticles (Chi-TA-NPs). The results were reported in µg/mL. PTCC Persian Type Culture Collection, ATCC American Type Culture Collection, MIC minimum inhibitory concentration, MBC minimum bactericidal concentration, MFC minimum fungicidal concentration. Cytotoxicity analysis of Chi-TA-NPs in HepG2 cells The effects of Chi-TA-NPs on the growth of HepG2 cells were demonstrated for the first time using the MTT assay. HepG2 HCC cells were treated with different concentrations of Chi-TA-NPs, Chi-NPs and free TA for 48 h. Chi-TA-NPs dose-dependently reduced HepG2 cell viability (Fig. 4). In addition, the IC50 value (500 µg/mL) of Chi-TA-NPs against HepG2 cells was lower than that of free TA. At various concentrations, including 500 µg/mL, the growth inhibitory effect of Chi-TA-NPs on HepG2 cells was greater than that of free TA (Fig. 4). Geng et al. investigated the cytotoxic effects of free TA on HepG2 cells and reported an IC50 value of 612.43 µg/mL69. Therefore, the cytotoxic effects of TA were enhanced by encapsulation in Chi-NPs. The high anticancer activity of Chi-TA-NPs may have resulted from their continuous release and high cellular absorption59,70. Free drugs diffuse through the cell membrane, whereas polymeric NPs loaded with the drug enter the cells through a distinct pathway and release the drug in a well-organized manner59. The underlying mechanisms of the Chi-TA-NPs-induced cytotoxic effects were not clarified in this study. We hypothesized that cell cycle arrest, apoptosis induction, and reactive oxygen species (ROS) generation would mediate the cytotoxic effects of Chi-TA-NPs on HepG2 cells71,72. However, this hypothesis needs additional investigation. To decrease the toxicity of free TA and the prepared Chi-TA-NPs and to ensure considerable inhibition of HepG2 cells, approximately 20–30% inhibition induced by sublethal concentrations of free TA and Chi-TA-NPs (100 µg/mL) was selected for subsequent experiments.Fig. 4Cytotoxic effects of chitosan-based tannic acid nanoparticles (Chi-TA-NPs) on HepG2 cells. HepG2 cell survival was examined using the MTT method after exposure to chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and Chi-TA-NPs for 48 h. Cytotoxic effects of chitosan-based tannic acid nanoparticles (Chi-TA-NPs) on HepG2 cells. HepG2 cell survival was examined using the MTT method after exposure to chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and Chi-TA-NPs for 48 h. Effects of Chi-TA-NPs on DNMTs gene expression To examine whether DNMTs expression was altered by Chi-TA-NPs, HepG2 cells were exposed to sub-lethal concentrations (100 µg/mL) of Chi-NPs, free TA, and Chi-TA-NPs for 48 h. As shown in Fig. 5, treatment of HepG2 cells with Chi-TA-NPs significantly reduced the gene expression levels of DNMT1, DNMT3A, and DNMT3B (60%, 66%, and 66%, respectively) compared to those in control HepG2 cells (p < 0.05). However, DNMT1 expression was not significantly altered in HepG2 cells following free TA treatment (p > 0.05; Fig. 5). Furthermore, the average gene expression levels of DNMTs were noticeably decreased by 64% in Chi-TA-NPs-treated cells compared with untreated control cells (p < 0.05; Fig. 5). As expected, treatment with Chi-TA-NPs or free TA regulated DNMTs, and Chi-TA-NPs had a more pronounced effect. DNMTs overexpression contributes to HCC carcinogenesis by repressing tumor suppressor genes73. Additionally, it is correlated with a poor prognosis in patients with HCC73. Moreover, the role of DNMTs in HCC chemoresistance is well documented74. These results followed previous studies, indicating a role for polyphenols in the downregulation of DNMTs in cancer cells75. Overall, our results showed that Chi-TA-NPs had a higher inhibitory activity on DNMTs than free TA, suggesting the potential of Chi-TA-NPs to inhibit DNMTs-mediated HCC progression.Fig. 5Gene expression levels of DNA methyltransferases (DNMTs) in HepG2 cells exposed to 100 µg/mL chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and chitosan-based tannic acid nanoparticles (Chi-TA-NPs) for 48 h. Groups with various letters (a, b and c) differ significantly from other groups. Gene expression levels of DNA methyltransferases (DNMTs) in HepG2 cells exposed to 100 µg/mL chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and chitosan-based tannic acid nanoparticles (Chi-TA-NPs) for 48 h. Groups with various letters (a, b and c) differ significantly from other groups. Effects of Chi-TA-NPs on global DNA methylation A decrease in genomic methylation, also recognized as global DNA hypomethylation, is a consistent epigenetic modification in HCC76,77. Global DNA hypomethylation contributes to HCC carcinogenesis by promoting chromosomal instability76,77. Moreover, it is associated with poor survival of patients with HCC76. As shown in Fig. 6, the level of methylated cytosine in the genomic DNA of untreated HepG2 cells was approximately 0.995%. However, 0.997, 0.992, and 0.990% of cytosines were methylated in HepG2 cancer cells exposed to TA, Chi-NPs, and Chi-TA-NPs, respectively. No significant alterations were detected in the levels of global genomic DNA methylation in HepG2 cells after treatment with free TA or Chi-TA-NPs (p > 0.05; Fig. 6). We hypothesized that if the concentration used for Chi-TA-NPs exposure was greater than 100 µg/mL, or if the duration of Chi-TA-NPs treatment was more than 48 h, it is more likely that the changes in global DNA methylation would be more pronounced in HepG2 cells.Fig. 6Levels of 5-methylcytosine (5-mC) in HepG2 cells exposed to 100 µg/mL chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and chitosan-based tannic acid nanoparticles (Chi-TA-NPs) for 48 h. Bars represent the mean ± SD. NS not significant. Levels of 5-methylcytosine (5-mC) in HepG2 cells exposed to 100 µg/mL chitosan-based nanoparticles (Chi-NPs), tannic acid (TA), and chitosan-based tannic acid nanoparticles (Chi-TA-NPs) for 48 h. Bars represent the mean ± SD. NS not significant. In this study, we assessed the cytotoxic and epigenetic effects of Chi-TA-NPs in vitro. This warrants further in vivo investigation and suggests the need for further studies on the underlying mechanisms of the detected effects. In addition, the optimum dose and duration of Chi-TA-NPs exposure and intracellular TA concentration necessitate more investigation. Conclusions In this study, Chi-TA-NPs were successfully prepared and identified for potential antimicrobial activity against microbial pathogens and anticancer effects on HepG2 cells. Various physicochemical characterizations and biological analyses were conducted to validate this hypothesis. The prepared particles exhibited a nanometer-scale size and release pattern for TA following the Korsmeyer-Peppas model. Encapsulated TA caused greater inhibitory effects on the growth of pathogenic microbial strains than free TA did. Chi-TA-NPs showed greater cytotoxic activity against HepG2 cells than free TA and reduced HepG2 cell viability in a dose-dependent manner. Additionally, Chi-TA-NPs significantly reduced DNMTs expression in HepG2 cells, and their inhibitory effects on DNMTs were more pronounced than those of free TA. Overall, these results revealed the increased antimicrobial activity and cytotoxic and epigenetic effects of TA on HepG2 cells after loading into Chi-NPs. These findings demonstrated the potential of Chi-TA-NPs in controlling infectious diseases and HCC.